- Home
- ARMP vs OPHC Comparison
ARMP vs OPHC Comparison
Compare ARMP & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- OPHC
- Stock Information
- Founded
- ARMP N/A
- OPHC 2000
- Country
- ARMP United States
- OPHC United States
- Employees
- ARMP N/A
- OPHC N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- OPHC Major Banks
- Sector
- ARMP Health Care
- OPHC Finance
- Exchange
- ARMP Nasdaq
- OPHC Nasdaq
- Market Cap
- ARMP 52.1M
- OPHC 51.8M
- IPO Year
- ARMP N/A
- OPHC N/A
- Fundamental
- Price
- ARMP $2.54
- OPHC $4.52
- Analyst Decision
- ARMP Strong Buy
- OPHC
- Analyst Count
- ARMP 1
- OPHC 0
- Target Price
- ARMP $9.00
- OPHC N/A
- AVG Volume (30 Days)
- ARMP 13.2K
- OPHC 18.2K
- Earning Date
- ARMP 08-12-2025
- OPHC 08-12-2025
- Dividend Yield
- ARMP N/A
- OPHC N/A
- EPS Growth
- ARMP N/A
- OPHC 30.24
- EPS
- ARMP N/A
- OPHC 1.33
- Revenue
- ARMP $4,699,000.00
- OPHC $39,980,000.00
- Revenue This Year
- ARMP $8.43
- OPHC N/A
- Revenue Next Year
- ARMP N/A
- OPHC N/A
- P/E Ratio
- ARMP N/A
- OPHC $3.39
- Revenue Growth
- ARMP 14.24
- OPHC 53.28
- 52 Week Low
- ARMP $0.90
- OPHC $3.53
- 52 Week High
- ARMP $2.96
- OPHC $5.90
- Technical
- Relative Strength Index (RSI)
- ARMP 65.04
- OPHC 48.55
- Support Level
- ARMP $2.14
- OPHC $4.56
- Resistance Level
- ARMP $2.61
- OPHC $4.70
- Average True Range (ATR)
- ARMP 0.14
- OPHC 0.06
- MACD
- ARMP -0.00
- OPHC -0.01
- Stochastic Oscillator
- ARMP 81.08
- OPHC 14.29
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.